The new article describes the approach to be followed by the applicants when presenting sufficient evidence demonstrating the proper performance of their products when used for the intended purpose.
The new article describes in detail the aspects related to different types of MRI safety labelling to be used to indicate the safety status of the device intended to be marketed and used in the US.
The article highlights the key points related to the responsibilities of persons using healthcare products in the context of reporting adverse reactions thereto.
The new article highlights the aspects related to the device description to be included in premarket notification submissions under the respective legal framework.